Zhu Y, Yang Z, Luo X-H, Xu P
Department of Radiation Oncology, Baoji Central Hospital, Baoji, China.
Eur Rev Med Pharmacol Sci. 2021 Feb;25(3):1165. doi: 10.26355/eurrev_202102_24813.
Since this article has been suspected of research misconduct and the corresponding authors did not respond to our request to prove originality of data and figures, "Long noncoding RNA TTN-AS1 promotes the proliferation and migration of prostate cancer by inhibiting miR-1271 level, by Y. Zhu, Z. Yang, X.-H. Luo, P. Xu, published in Eur Rev Med Pharmacol Sci 2019; 23 (24): 10678-10684-DOI: 10.26355/eurrev_201912_19766-PMID: 31858535" has been withdrawn. The Publisher apologizes for any inconvenience this may cause. https://www.europeanreview.org/article/19766.
由于本文被怀疑存在研究不当行为，且通讯作者未回应我们关于证明数据和图表原创性的要求，“Y. Zhu、Z. Yang、X.-H. Luo、P. Xu发表于《欧洲医学与药理学评论》2019年；23(24): 10678 - 10684 - DOI: 10.26355/eurrev_201912_19766 - PMID: 31858535的《长链非编码RNA TTN - AS1通过抑制miR - 1271水平促进前列腺癌的增殖和迁移》”已被撤回。出版方对由此可能造成的任何不便表示歉意。https://www.europeanreview.org/article/19766 。
